Figure 6

CNE2 cells were transfected with FMNL3-specific siRNA (siFMNL3 oligo 1), control siRNA (siNC), or no siRNA (MOCK) and then treated with or without TGF-β1 (10 ng/ml) for 48 h. The cells were harvested and used in transwell migration assays (A,C) and wound healing assays (B,D). Untreated CNE2 cells served as controls. Each group was analysed in three wells (n = 3). Scale bars, 60 μm (A) and 200 μm (B). **p < 0.01.